Your session is about to expire
β Back to Search
Exercise Intervention for Post-Surgical Lung Cancer Fatigue
N/A
Recruiting
Led By Amy J Hoffman, PhD, RN
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
With suspected non-small cell lung cancer to be confirmed after surgery
Medically stable comorbid conditions allowing for non-small cell lung cancer surgery clearance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up about 6 weeks after discharge from the hospital
Awards & highlights
Study Summary
This trial is testing a new exercise intervention to help reduce cancer-related fatigue for post-thoracotomy lung cancer patients.
Who is the study for?
This trial is for adults with suspected non-small cell lung cancer, confirmed post-surgery. Participants must be stable enough for surgery, have a performance status score of at least 70%, and live within 2 hours of the recruitment site. They need phone access, speak English, and own a TV. Exclusions include severe sensory impairments, recent active treatment for other cancers, plans to relocate soon or weigh over 330 pounds.Check my eligibility
What is being tested?
The study tests a new rehabilitative intervention aimed at managing fatigue after lung cancer surgery through support education and light physical activities. It's designed to be low-cost and safe while improving quality of life by reducing fatigue severity in post-thoracotomy patients.See study design
What are the potential side effects?
Since this trial involves educational support and light exercises rather than medication or invasive procedures, side effects are minimal but may include general discomfort or muscle soreness associated with physical activity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowSelect...
My lung cancer type will be confirmed after surgery.
Select...
My health allows me to have surgery for non-small cell lung cancer.
Select...
I am able to care for myself but may not be able to do active work.
Select...
I live within 2 hours drive from the study site.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ about 6 weeks after discharge from the hospital
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~about 6 weeks after discharge from the hospital
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Malignant Neoplasms
Cancer-Related Fatigue Severity as assessed using an 11-point rating scale
Secondary outcome measures
Activities-Specific Balance Confidence
Functional Status Performance
Other Symptoms Severity
+4 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Light Physical Activity 2Experimental Treatment1 Intervention
Conventional treatment for cancer as prescribed by the participant's health care providers and will receive a home-based light (mild) physical activity program that begins approximately within one week after discharge from the hospital with the physical activity program starting approximately 7 weeks post-discharge from the hospital.
Group II: Light Physical Activity 1Experimental Treatment1 Intervention
Conventional treatment for cancer as prescribed by the participant's health care providers and will receive a home-based light (mild) physical activity program that begins approximately within one week after discharge from the hospital with the physical activity program starting approximately within the first week post-discharge from the hospital.
Group III: Support Education ActivityActive Control1 Intervention
Conventional treatment for cancer as prescribed by the participant's health care providers and will participate in a supportive cancer-related education activity each week for 6-weeks after returning home from the hospital.
Find a Location
Who is running the clinical trial?
Munson Medical CenterOTHER
2 Previous Clinical Trials
120 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,874 Total Patients Enrolled
The Methodist Hospital Research InstituteOTHER
271 Previous Clinical Trials
80,096 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am at least 18 years old in Michigan or 19 in Nebraska.A thoracic surgeon has approved my surgery before and after the procedure.I have severe problems with my sight, hearing, or speaking.I haven't had cancer treatment in the last 3 months, except for stable breast or prostate cancer.My lung cancer type will be confirmed after surgery.My health allows me to have surgery for non-small cell lung cancer.You have had seizures triggered by bright lights or flashing images.I am able to care for myself but may not be able to do active work.My weight is over 330 pounds.I can hear and speak clearly for phone calls.I live within 2 hours drive from the study site.This criterion does not seem to fit within a typical clinical trial exclusion criteria. If you have further details or context, I would be happy to help in any way I can.I am either a woman or a man.
Research Study Groups:
This trial has the following groups:- Group 1: Light Physical Activity 1
- Group 2: Light Physical Activity 2
- Group 3: Support Education Activity
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the chief aims of this research endeavor?
"This research initiative is focused on assessing Cancer-Related Fatigue Severity using an 11-point scale over a 6 week post-discharge period. Secondary objectives include gauging Perceived Self-Efficacy for Fatigue Management, Activities Specific Balance Confidence (on an 0 - 100% scale), and Quality of Life (measured 1 β 6)."
Answered by AI
Is enrollment still available for this clinical experiment?
"Affirmative. As seen on clinicaltrials.gov, this ongoing research is currently recruiting participants and was first posted June 4th 2019 with the most recent update occurring June 20th 2022. The medical trial needs to find 279 individuals across one location."
Answered by AI
How many participants are currently involved in the research?
"Affirmative. As per information featured on clinicaltrials.gov, the trial - originally posted on June 4th 2019 - is currently recruiting participants. The research team needs to recruit 279 individuals from one site in total."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger